1.Distraction Osteogenesis Update: Introduction of Multidirectional Cranial Distraction Osteogenesis.
Akira GOMI ; Ataru SUNAGA ; Hideaki KAMOCHI ; Hirofumi OGUMA ; Yasushi SUGAWARA
Journal of Korean Neurosurgical Society 2016;59(3):233-241
In this review, we discuss in detail our current procedure for treating craniosynostosis using multidirectional cranial distraction osteogenesis (MCDO). The MCDO method allows all phenotypes of skull deformity to be reshaped by distraction osteogenesis, except in patients who are 5 months of age or younger and patients with posterior cranial vault problems. We report the results of clinical data of 36 children with craniosynostosis who underwent MCDO between 2005 and 2014 in our institute. This method has the following benefits, such as a high flexibility of reshaping, shorter treatment period and less invasive secondary intervention. We also discuss the other distraction osteogenesis techniques that are used to treat craniosynostosis and compare them with MCDO. The preferred procedure for correction of craniosynostosis may depend on the patient's age, the extent of deformity, and the extent of correction achievable by surgery. We can arrange the combinations of various methods according to the advantage and disadvantage of each technique.
Child
;
Congenital Abnormalities
;
Craniosynostoses
;
Humans
;
Osteogenesis, Distraction*
;
Phenotype
;
Pliability
;
Skull
2.Ongoing increase in measles cases following importations, Japan, March 2014: times of challenge and opportunity
Takuri Takahashi ; Yuzo Arima ; Hitomi Kinoshita ; Kazuhiko Kanou ; Takehito Saitoh ; Tomimasa Sunagawa ; Hiroaki Ito ; Atsuhiro Kanayama ; AyakoTabuchi ; Kazutoshi Nakashima ; Yuichiro Yahata ; Takuya Yamagishi ; Tamie Sugawara ; Yasushi Ohkusa ; Tamano Matsui ; Satoru Arai ; Hiroshi Satoh ; Keiko Tanaka-Taya ; Katsuhiro Komase ; Makoto Takeda ; Kazunori Oishi
Western Pacific Surveillance and Response 2014;5(2):31-33
Since late 2013 through March 2014, Japan experienced a rapid rise in measles cases. Here, we briefly report on the ongoing situation and share preliminarily findings, concerns and challenges and the public health actions needed over the coming months and years.
Measles is a notifiable disease in Japan based on nationwide case-based surveillance legally requiring physicians to report all clinically diagnosed and laboratory-confirmed cases within seven days, but preferably within 24 hours. After a large outbreak in 2007–2008 (more than 11 000 cases reported in 2008 alone) and a goal of elimination by April 2015, a catch-up programme using the bivalent measles-rubella (MR) vaccine was offered for grades seven and 12 (ages 12–13 and 17–18 years) from April 2008 through March 2013. During this period, there was an estimated 97% decline in measles notifications, and the cumulative number of reported cases has been steadily declining over the last five years (732 cases in 2009, 447 cases in 2010, 439 cases in 2011, 293 cases in 2012 and 232 cases in 2013). However, since late 2013 through March 2014, the country experienced a resurgence only a year after a large rubella outbreak.